Cetera Investment Advisers

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1666741 SCHAUMBURG, IL

Position in ARWR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,383,433

+$1,792,549 QoQ

Shares Held

29,241

+210.3% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#183

of 497 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. ARWR ranks #20 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	78,107	$38,798,090
2	IBRX	ImmunityBio, Inc.	1,140,476	$9,984,867
3	EXEL	Exelixis, Inc.	169,657	$9,231,037
4	REGN	Regeneron Pharmaceuticals, Inc.	14,664	$9,143,590
5	OCUL	Ocular Therapeutix, Inc	785,732	$7,715,888
6	ARGX	Argenx SE	7,844	$7,277,427
7	VKTX	Viking Therapeutics, Inc.	184,543	$7,199,022
8	ALNY	Alnylam Pharmaceuticals, Inc.	23,196	$6,982,691

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,383,433	29,241	+210.3%	Shares	Sole	2026-08-12
2026-03-31	$590,884	9,424	+40.7%	Shares	Sole	2026-05-13
2025-12-31	$444,613	6,697	-42.4%	Shares	Sole	2026-02-17
2024-09-30	$225,040	11,618	-16.9%	Shares	Sole	2024-11-13
2024-06-30	$363,392	13,982	+13.0%	Shares	Sole	2024-08-22
2024-03-31	$353,782	12,370	-89.7%	Shares	Sole	2024-05-24
2021-12-31	$7,927,159	119,565	+0.0%	Shares	Sole	2022-02-14
2021-09-30	$7,464,255	119,562	+12.9%	Shares	Sole	2021-11-16
2021-06-30	$8,772,294	105,920	-6.9%	Shares	Sole	2021-08-13
2021-03-31	$7,545,282	113,788	-1.1%	Shares	Sole	2021-05-17
2020-12-31	$8,830,855	115,090	+521.2%	Shares	Sole	2021-02-17
2020-09-30	$797,729	18,526	+14.8%	Shares	Sole	2020-11-13
2020-06-30	$696,870	16,135	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.